Skip to main content

Peer Review reports

From: Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

Original Submission
28 Sep 2020 Submitted Original manuscript
2 Nov 2020 Reviewed Reviewer Report
6 Nov 2020 Reviewed Reviewer Report
22 Nov 2020 Author responded Author comments - Sojung Park
Resubmission - Version 2
22 Nov 2020 Submitted Manuscript version 2
14 Dec 2020 Reviewed Reviewer Report
18 Dec 2020 Reviewed Reviewer Report
21 Dec 2020 Author responded Author comments - Sojung Park
Resubmission - Version 3
21 Dec 2020 Submitted Manuscript version 3
Publishing
23 Dec 2020 Editorially accepted
11 Jan 2021 Article published 10.1186/s12885-020-07765-6

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us